Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,398,463 papers from all fields of science
Search
Sign In
Create Free Account
Positive Contrast Agent
Contrast media that has a higher amplification and intensity than the surrounding tissue making the contrast look more opaque when seen in an x-ray.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
In vivo Imaging Biodistribution Profile of a New Macrocyclic Gadolinium Chelate as a Highly Stable Multifunctional MRI Contrast Agent
B. Sung
,
Y. Jo
,
Yongmin Chang
Investigative Magnetic Resonance Imaging
2019
Corpus ID: 133316871
Small molecular weight gadolinium chelate is a positive contrast agent (CA) for magnetic resonance imaging (MRI), used to…
Expand
Review
2014
Review
2014
Improvement of distension and mural visualization of bowel loops using neutral oral contrasts in abdominal computed tomography.
J. Hashemi
,
Y. Davoudi
,
M. Taghavi
,
Masoud Pezeshki Rad
,
Amien Mahajeri Moghadam
World Journal of Radiology
2014
Corpus ID: 11419187
AIM To assess and compare the image quality of 4% sorbitol and diluted iodine 2% (positive oral contrast agent) in abdomino…
Expand
2010
2010
Evaluation of Gd-DTPA contrast enhancement of lung and metastatic tumor with ultra-short echo-time imaging
D. Kokuryo
,
I. Aoki
,
T. Saga
2010
Corpus ID: 47004406
Introduction In a previous study, we administered nanoparticles containing a MR contrast agent, a fluorescence dye and an…
Expand
Review
2001
Review
2001
[Two-dimensional and three-dimensional CT diagnosis of alimentary tract].
N. Shiraga
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta…
2001
Corpus ID: 23650724
The recent development of multidetector-row CT(MDCT) has made it possible to obtain three-dimensional images of the alimentary…
Expand
2000
2000
Positive and negative oral contrast agents for combined abdominal and pelvic helical CT: first iodinated agent and second water.
Yujiro Matsuoka
,
T. Masumoto
,
+7 authors
Noriko Kamata
Radiation Medicine
2000
Corpus ID: 29967157
Combined abdominal and pelvic helical computed tomography (CT) with intravenous contrast media was performed on 19 patients with…
Expand
1999
1999
Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging.
S. Grubnic
,
A. Padhani
,
P. Revell
,
J. Husband
AJR. American journal of roentgenology
1999
Corpus ID: 45426497
OBJECTIVE Our objective was to compare the efficacy of a positive and a negative oral contrast agent and to determine the optimal…
Expand
1999
1999
Contrast enhanced MRA of peripheral arteries with the automatic "floating table".
R. Janka
,
F. Fellner
,
+4 authors
W. Bautz
Röntgenpraxis; Zeitschrift für radiologische…
1999
Corpus ID: 867348
Magnetic resonance angiography (MRA) is increasingly used as a non-invasive alternative to digital subtraction angiography (DSA…
Expand
1999
1999
Duodenal duplication cyst: MR imaging appearance
A. Rotondo
,
M. Scialpi
,
G. Pellegrino
,
F. Salzano de Luna
,
L. Coppola
,
G. Angelelli
European Radiology
1999
Corpus ID: 24017624
Abstract. The MR imaging appearance of a duodenal duplication cyst is reported. MR imaging confirmed the diagnosis suggested by…
Expand
1995
1995
Technical note: dynamic analysis of the pharynx during swallowing using Turbo-FLASH magnetic resonance imaging combined with an oral positive contrast agent--a preliminary study.
Y. Suto
,
M. Kamba
,
T. Kato
British Journal of Radiology
1995
Corpus ID: 25937800
Serial images of the swallowing motions of 10 healthy volunteers were taken using the Turbo-fast low angle shot (FLASH) magnetic…
Expand
1993
1993
Adenography: an ancillary diagnostic method of circumscribed lesions of the breast with a positive contrast agent
M. Lehto
,
T. Mathiesen
1993
Corpus ID: 79239478
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE